Clinical Trials Logo

Clinical Trial Summary

ItaliTTP is an observational, prospective, single-arm, national, multicenter, non-pharmacological cohort study aimed at better defining and understanding the natural history, disease severity, and clinical outcomes of patients with immune-mediated thrombotic thrombocytopenic purpura (iTTP) in Italy. A minimum of 132 consecutive patients with acute iTTP (first event or relapse) will be enrolled for 3 years, with the possibility of extension, with a follow-up period of 3 years.


Clinical Trial Description

Acquired immune-mediated thrombotic thrombocytopenic purpura (iTTP) is a rare, life-threatening thrombotic microangiopathy characterized by episodes of thrombocytopenia, microangiopathic hemolytic anemia, and extensive microvascular thrombosis leading to multiorgan involvement. Despite advances in understanding iTTP etiology and management in the acute phase, significant gaps in knowledge about its progression, particularly during clinical remission and concerning long-term complications, persist. ItaliTTP, a national, multicenter, observational, prospective, non-pharmacological cohort study, aims to elucidate the natural history, severity, and outcomes of iTTP in Italy. The study will enroll hospitalized iTTP patients (experiencing either initial or recurrent episodes) and follow them in outpatient settings across participating Italian centers. The study plans to include at least 132 patients of any gender, aged 12 to 99, over a three-year period, with an option for extension, and a three-year follow-up. During hospitalization and subsequent outpatient visits, participants will undergo routine clinical assessments and laboratory tests. In addition to these data, peripheral blood samples will be collected for ADAMTS13 analysis and potential future research. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06376786
Study type Observational [Patient Registry]
Source Fondazione Luigi Villa
Contact Sandra Maccarone
Phone +39 02 551 0709
Email contact@fondazioneluigivilla.org
Status Not yet recruiting
Phase
Start date June 1, 2024
Completion date May 31, 2030

See also
  Status Clinical Trial Phase
Recruiting NCT05571774 - Construction of a Database for TTP
Recruiting NCT03832881 - The United Kingdom Thrombotic Thrombocytopenic Purpura Registry (UK TTP Registry)
Recruiting NCT05950750 - Turkey Thrombotic Thrombocytopenic Purpura Disease Registry: National Multicenter Study